Obstetrics/Gynecology
RSSArticles
-
An Arcuate Uterus (Apparently) Does Not Impair Fertility
No decreases in implantation rates and live birth rates were present in a retrospective study from a single fertility center examining outcomes of in vitro fertilization in women with an arcuate uterus.
-
Does Childhood Adversity Affect the Menopausal Transition?
The number and timing of adverse childhood experiences in relation to puberty affect the risk of incident major depressive disorder in the menopausal transition.
-
With Funding Announcement, Trump Begins Reshaping Title X
Funding announcement to reshape Title X.
-
What’s Your Approach to Abnormal Uterine Bleeding?
Statistics indicate that one-third of outpatient gynecologist visits are for abnormal uterine bleeding, with the condition accounting for more than 70% of gynecologic consultations in the perimenopausal and postmenopausal years.
-
Research Examines Self-administered DMPA
New research indicates that use of subcutaneous depot medroxyprogesterone (DMPA-SC, marketed as Sayana Press, Pfizer Inc.) may help women to continue using injectable contraception longer than women who receive traditional intramuscular injections.
-
Push Is on to Combat Drug-resistant Gonorrhea
In a recently released study, Centers for Disease Control and Prevention (CDC) researchers report that while 81% of patients diagnosed with gonorrhea were treated using dual therapy, nearly one in five were treated with a different regimen.
-
FDA Issues Restrictions for Sterilization Option
The Food and Drug Administration has issued new restrictions regarding the sale and distribution of the permanent contraceptive device, Essure.
-
Check Your Clinical Practice for LARC Methods
The American College of Obstetricians and Gynecologists now recognizes immediate postpartum placement of either the intrauterine device or the contraceptive implant as a best practice because of the long-acting reversible contraceptive methods’ role in preventing rapid repeat and unintended pregnancy
-
The Risk of Malignancy in Hysterectomy
There has been significant publicity about the risk of malignancy associated with morcellation in hysterectomy, but in reality the incidence is quite low.
-
Is Vaginal Estrogen Still the Gold Standard for Treating GSM?
In this 12-week randomized, controlled trial of 302 women, neither vaginal estrogen nor vaginal moisturizer was more effective than placebo for reducing the participants’ most bothersome symptom (pain with vaginal penetration, vulvovaginal itching, vulvovaginal pain, vaginal dryness, or vulvovaginal irritation).